Pregnancy Outcomes After Early Fetal Exposure to Injectable First-Line Treatments, Dimethyl Fumarate, or Natalizumab in Danish Women With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate or natalizumab in Danish women with multiple sclerosis
Eur. J. Neurol. 2022 Sep 13;[EPub Ahead of Print], JB Andersen, F Sellebjerg, M MagyariFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.